Abstract
Previously reported serologic and polymerase chain reaction (PCR)-based findings have suggested an association between the human retrovirus, HTLV-I, and multiple sclerosis (MS). Due to the inherent ability of PCR to produce false-positive results, we developed a set of physical and procedural safeguards to minimize the possibility of molecular carryover. These were applied as part of a blinded, large-scale, multipopulation, multiplex PCR-based study designed to examine this issue of association. Our results do not support the hypothesis that HTLV-I, which plays a role in the pathogenesis of an encepha- lomyeloneuropathy, HTLV-II, or closely related agents are associated with MS. A concomitant review of the current literature supports this view.
| Original language | English |
|---|---|
| Pages (from-to) | 335-343 |
| Number of pages | 9 |
| Journal | Neurology |
| Volume | 41 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1991 |
| Externally published | Yes |